当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ranking Important Factors for Using Postoperative Chemotherapy in Non-Muscle Invasive Bladder Cancer: Conjoint Analysis Results From the Michigan Urological Surgery Improvement Collaborative (MUSIC).
The Journal of Urology ( IF 5.9 ) Pub Date : 2021-09-23 , DOI: 10.1097/ju.0000000000002233
Clint Cary 1, 2 , Yan Tong 3 , Susan Linsell 4 , Khurshid Ghani 4 , David C Miller 4 , Michael Weiner 2, 5 , Michael O Koch 1 , Susan M Perkins 3 , Gregory Zimet 6
Affiliation  

National and International guidelines recommend the use of one dose of intravesical chemotherapy immediately following surgery for non-muscle invasive bladder cancer, which is performed infrequently on a population level. We sought to understand the importance of potential environmental and clinical dimensions involved in the decision to offer this therapy.

中文翻译:


对非肌肉浸润性膀胱癌术后化疗的重要因素进行排名:来自密歇根泌尿外科改进协作组织 (MUSIC) 的联合分析结果。



国家和国际指南建议在非肌层浸润性膀胱癌手术后立即使用一剂膀胱内化疗,这种手术在人群水平上很少进行。我们试图了解提供这种疗法的决定所涉及的潜在环境和临床因素的重要性。
更新日期:2021-09-23
down
wechat
bug